series-c-plus
Stage
2
Investors
About
Ikena Oncology discovers and develops targeted cancer therapies by identifying and inhibiting novel kinases that drive tumor growth and contribute to drug resistance.
Explore Ikena Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.